Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Other Working Capital Changes (2016 - 2025)

Jaguar Health (JAGX) has disclosed Other Working Capital Changes for 11 consecutive years, with -$985000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 13.97% to -$985000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$324000.0, a 115.77% decrease, with the full-year FY2024 number at -$451000.0, down 109.0% from a year prior.
  • Other Working Capital Changes was -$985000.0 for Q3 2025 at Jaguar Health, down from $838000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.6 million in Q2 2023 to a low of -$1.2 million in Q3 2023.
  • A 5-year average of $233842.1 and a median of -$42000.0 in 2024 define the central range for Other Working Capital Changes.
  • Biggest YoY gain for Other Working Capital Changes was 2399.04% in 2023; the steepest drop was 1242.53% in 2023.
  • Jaguar Health's Other Working Capital Changes stood at -$961000.0 in 2021, then surged by 89.18% to -$104000.0 in 2022, then skyrocketed by 2399.04% to $2.4 million in 2023, then plummeted by 104.77% to -$114000.0 in 2024, then tumbled by 764.04% to -$985000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Other Working Capital Changes are -$985000.0 (Q3 2025), $838000.0 (Q2 2025), and -$63000.0 (Q1 2025).